April 24, 2024

A recent study by Japanese researchers found that although there were no excess cancer deaths in Japan during the first year of the Covid-19 outbreak, researchers noticed an increase in cancer mortality during the period of mass vaccination. Some excess cancer mortalities were observed in 2021 after mass vaccination with the first and second vaccine doses, and significant excess mortalities were observed for all cancers and some specific types of cancer (including ovarian cancer, leukemia, prostate cancer, lip/oral/pharyngeal cancer, pancreatic cancer, and breast cancer) after mass vaccination with the third dose in 2022. Japan administered Western mRNA COVID shots, 78% were manufactured by Pfizer and 22% were from Moderna.

Read More HERE